Home
/
CytoDyn Inc.
/
Financials
/
Quarterly
CytoDyn Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that CytoDyn Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2021
Feb 28, 2022
$266.0K
Apr 11, 2022
Q2
2021
Nov 30, 2021
$225.0K
Jan 10, 2022
Q1
2021
Aug 31, 2021
$41.0K
Oct 12, 2021
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2023
Feb 28, 2022
$266.0K
Apr 10, 2023
Q2
2023
Nov 30, 2021
$225.0K
Jan 9, 2023
Q1
2023
Aug 31, 2021
$41.0K
Oct 13, 2022
Q3
2021
Feb 28, 2021
$0
Apr 11, 2022
Q2
2021
Nov 30, 2020
$0
Jan 10, 2022
Q1
2021
Aug 31, 2020
$0
Oct 12, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Feb 28, 2026
($4.69M)
Apr 8, 2026
Q2
2026
Nov 30, 2025
($22.61M)
Jan 9, 2026
Q3
2026
Nov 30, 2025
($22.61M)
Apr 8, 2026
Q1
2026
Aug 31, 2025
($5.54M)
Oct 10, 2025
Q2
2026
Aug 31, 2025
($5.54M)
Jan 9, 2026
Q3
2026
Aug 31, 2025
($5.54M)
Apr 8, 2026
Q3
2026
Feb 28, 2025
($4.76M)
Apr 8, 2026
Q2
2026
Nov 30, 2024
($4.77M)
Jan 9, 2026
Q3
2026
Nov 30, 2024
($4.77M)
Apr 8, 2026
Q1
2026
Aug 31, 2024
$19.23M
Oct 10, 2025
Q3
2026
Aug 31, 2024
$19.23M
Apr 8, 2026
Q2
2026
Aug 31, 2024
$19.23M
Jan 9, 2026
Q3
2025
Feb 29, 2024
($11.92M)
Apr 14, 2025
Q2
2025
Nov 30, 2023
($9.56M)
Jan 14, 2025
Q3
2025
Nov 30, 2023
($9.56M)
Apr 14, 2025
Q2
2025
Aug 31, 2023
($11.57M)
Jan 14, 2025
Q1
2025
Aug 31, 2023
($11.57M)
Oct 15, 2024
Q3
2025
Aug 31, 2023
($11.57M)
Apr 14, 2025
Q3
2024
Feb 28, 2023
($13.70M)
Apr 15, 2024
Q3
2024
Nov 30, 2022
($26.50M)
Apr 15, 2024
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Feb 28, 2026
($6.30M)
Apr 8, 2026
Q2
2026
Nov 30, 2025
($21.69M)
Jan 9, 2026
Q1
2026
Aug 31, 2025
($4.95M)
Oct 10, 2025
Q3
2026
Feb 28, 2025
($4.00M)
Apr 8, 2026
Q2
2026
Nov 30, 2024
($3.71M)
Jan 9, 2026
Q1
2026
Aug 31, 2024
$22.44M
Oct 10, 2025
Q3
2025
Feb 29, 2024
($3.41M)
Apr 14, 2025
Q2
2025
Nov 30, 2023
($3.40M)
Jan 14, 2025
Q1
2025
Aug 31, 2023
($4.61M)
Oct 15, 2024
Q3
2024
Feb 28, 2023
($3.92M)
Apr 15, 2024
Q2
2024
Nov 30, 2022
($23.16M)
Jan 16, 2024
Q1
2024
Aug 31, 2022
($9.71M)
Oct 23, 2023
Q3
2023
Feb 28, 2022
($19.40M)
Apr 10, 2023
Q2
2023
Nov 30, 2021
($25.32M)
Jan 9, 2023
Q1
2023
Aug 31, 2021
($21.64M)
Oct 13, 2022
Q3
2021
Feb 28, 2021
($30.79M)
Apr 11, 2022
Q2
2021
Nov 30, 2020
($24.50M)
Jan 10, 2022
Q1
2021
Aug 31, 2020
($25.57M)
Oct 12, 2021
Q3
2020
Feb 29, 2020
($22.08M)
Apr 14, 2021
Q2
2020
Nov 30, 2019
($12.12M)
Jan 8, 2021